Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma.

Abstract

To identify prognostic indicators in patients treated with radiotherapy (RT) for metastases from hepatocellular carcinoma (HCC) in abdominal lymph nodes (LNs). RT was used to treat 65patients for metastases from HCC in abdominal LNs. Total radiation dose was 30-60Gy (median 52.8Gy), with fraction size 1.8-3Gy. RT was administered five times per week to an equivalent dose in 2-Gy fractions (EQD2; Gy10) of 32.5-65Gy10 (median 54Gy10) and an α/βratio for tumor and acute effects of normal tissue of10. Median overall survival (OS) in all patients was 8.1months. LN responders had significantly higher median OS than nonresponders (14.5vs. 3.7months, p < 0.05). Multivariate analysis showed that Child-Pugh classification, status of intrahepatic tumor, number of metastatic LNs, and LN response were independently predictive of OS (p < 0.05 each). Based on results of multivariate analysis, patients were prognostically stratified according to pretreatment risk factors, including Child-Pugh classification, intrahepatic tumor status, and number of metastatic LNs; with the expected median OS in patients with ≥ 2,1, and 0risk factors being 2.9,9.8, and 27.6months, respectively (p < 0.05). Our data showed that LN response to RT was an independent prognostic factor for OS in advanced HCC patients with abdominal LN metastases, and suggested that RT for metastatic LNs might improve OS in these patients. In addition, our data suggest that Child-Pugh classification, intrahepatic tumor status, and number of metastatic LNs may be useful prognostic and therapeutic indicators for selecting treatment strategies.